1 – 5 of 15
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE
(
- Contribution to journal › Article
- 2023
-
Mark
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry
(
- Contribution to journal › Debate/Note/Editorial
- 2022
-
Mark
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients
(
- Contribution to journal › Article
-
Mark
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
(
- Contribution to journal › Article
- 2021
-
Mark
OPTIMISATION in X-RAY and MOLECULAR IMAGING 2020
(
- Contribution to journal › Debate/Note/Editorial